Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells

Fig. 2

pMSCs proliferation and viability. a Experimental schedule. BM basal medium. b Untreated pMSCs, pMSCs pretreated with 1 ug/mL of LL-37 (1 LL37pre) or with 10 ug/mL of LL-37 (10 LL37pre), and pMSCs treated with 1 ug/mL LL-37 (1 LL371d) or with 10 ug/mL of LL-37 (10 LL371d) were cultured for 7 days, then cell proliferation/viability was assessed by MTT. There was no difference of proliferation/viability among groups. Values represent the means ± SEM. Three independent experiments (biological replicates) were performed. LL-37 cathelicidin LL-3. pMSCs human placenta-derived MSCs

Back to article page